GGrantIndex
Sort

48,018 grants matching immunotherapy

SPORE University of Texas M. D. Anderson Cancer Center-Leukemia

$1,708,776
Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA

UCLA SPORE in Prostate Cancer

$1,708,652
Robert E Reiter · University Of California Los Angeles · P50 · FY2019 · CA

Towards Eradication: Reducing Proviral HIV DNA with Interferon-a Immunotherapy

$1,708,367
Luis J. Montaner · Wistar Institute · U01 · FY2014 · AI

Engineering HCC-selective PET agent

$1,707,995
Freddy Escorcia · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC

$1,707,351
Jonathan P Schneck · Johns Hopkins University · P41 · FY2019 · EB

ADULT AIDS CLINICAL TRIALS UNIT

$1,705,127
New York University School Of Medicine · U01 · FY2001 · AI

Genome Instability Induced Anti-Tumor Immune Responses

$1,703,863
Roger A Greenberg · University Of Pennsylvania · P01 · FY2023 · CA

EPITHELIAL OVARIAN CANCER PROGRAM PROJECT

$1,703,177
Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA

Metabolic regulation of T cell effector function and anti-tumor immunotherapy

$1,702,553
Naomi Taylor · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Strategies to Overcome Immune Resistance in Head and Neck Cancers

$1,702,538
Sara Isabel Pai · Massachusetts General Hospital · P01 · FY2022 · CA

Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19

$1,701,970
Carl H. June · University Of Pennsylvania · P01 · FY2020 · CA

Developmental Funds

$1,701,922
Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2017 · CA

Crystallographic studies of macromolecular structures

$1,701,147
Lars Pedersen · National Institute Of Environmental Health Sciences · ZIC · FY2024 · ES

Moffitt Skin Cancer SPORE

$1,699,611
Vernon K. Sondak · H. Lee Moffitt Cancer Ctr & Res Inst · P50 · FY2015 · CA

A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies

$1,699,322
Jing Zhou · Isoplexis, Inc. · R44 · FY2019 · CA

AIDS CLINICAL TRIALS UNIT

$1,699,170
Harvard University (Medical School) · U01 · FY2002 · AI

Adult Leukemia Research Center

$1,697,384
Geoffrey Roger Hill · Fred Hutchinson Cancer Research Center · P01 · FY2021 · CA

Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer

$1,697,258
Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2018 · DC

AIDS CLINICAL TRIALS UNIT

$1,696,728
University Of Pennsylvania · U01 · FY2001 · AI

The Molecular Biology Of Experimental and Clinical Immune Tolerance

$1,696,151
Jack Ragheb · National Eye Institute · Z01 · FY2007 · EY

The Tisch Cancer Institute - Cancer Center Support Grant

$1,695,000
Steven J. Burakoff · Icahn School Of Medicine At Mount Sinai · P30 · FY2015 · CA

The Boston Lung Cancer Survival Cohort

$1,694,687
David C Christiani · Harvard School Of Public Health · U01 · FY2017 · CA

AIDS CLINICAL TRIALS UNIT

$1,693,188
Stanford University · U01 · FY2002 · AI

Analysis of cancer-related immune suppressor mechanisms in mice

$1,692,953
Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Novel Approaches to Stem Cell Transplantation

$1,692,811
Nelson J. Chao · Duke University · P01 · FY2006 · CA